Clinical sequencing in patients with refractory advanced cancers.

被引：0
|
作者：
Hijikata, Yasuki [1 ]
Yokoyama, Kazuaki [2 ]
Yamaguchi, Kiyoshi
Ikenoue, Tsuneo
Yamaguchi, Rui
Imoto, Seiya
Uchimaru, Kaoru
Miyano, Satoru
Yotsuyanagi, Hiroshi
Tojo, Arinobu
Furukawa, Yoichi
机构：
[1] IMSUT Hosp, Dept Palliat Care, Tokyo, Japan
[2] Dept Hematol, Tokyo, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OJ7-3-4
引用
收藏
页码：323 / 323
页数：1
相关论文
共 50 条
  • [1] Clinical implementation of whole genome multi-omics analyses for patients with refractory cancers.
    Radovich, Milan
    Kiel, Patrick
    Ratcliff, Katie
    Geiser, Andrew
    Jones, Shannon
    Hunter, Cynthia
    Finder, Rebecca
    Moller, Teresa
    Spradlin, Allison
    Koselke, Elizabeth
    Jones, Thomas
    Ibrahim, Sulfikar
    Schneider, Bryan Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Multi-analyte interrogation based treatment of advanced refractory cancers.
    Akolkar, Dadasaheb B.
    Crook, Timothy
    Patil, Darshana
    Ranade, Anantbhushan
    Bhatt, Amit
    Limaye, Sewanti
    Datta, Vineet
    Schuster, Stefan
    Sims, Cynthe
    Srivastava, Navin
    Fulmali, Pradip
    Fulmali, Pooja
    Devhare, Pradip
    Patil, Sanket
    Apurwa, Sachin
    Srinivasan, Ajay
    Datar, Rajan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Clinical next generation sequencing for precision oncology in rare cancers.
    Groisberg, Roman
    Hong, David S.
    Janku, Filip
    Tsimberidou, Apostolia Maria
    Javle, Milind M.
    Meric-Bernstam, Funda
    Subbiah, Vivek
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] POPULATION PHARMACOKINETICS OF PD 0332991 IN PATIENTS WITH ADVANCED CANCERS.
    Tortorici, M. A.
    O'Dwyer, P.
    LoRusso, P.
    Schwartz, G.
    Wilner, K.
    Ruiz-Garcia, A.
    Courtney, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S76 - S77
  • [5] Symptom burden, functional status, and clinical outcomes of hospitalized patients with advanced genitourinary cancers.
    Lage, Daniel E.
    Michaelson, Dror M.
    Sweeney, Christopher
    Barrett, Erika D.
    Olivier, Kara Marie
    Lee, Richard J.
    Greer, Joseph A.
    Temel, Jennifer S.
    El-Jawahri, Areej
    Nipp, Ryan David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [6] Multi-analyte liquid biopsies based treatment in advanced refractory cancers.
    Limaye, Sewanti
    Patil, Darshana
    Akolkar, Dadasaheb B.
    Crook, Timothy
    Ranade, Anantbhushan
    Bhatt, Amit
    Datta, Vineet
    Schuster, Stefan
    Sims, Cynthe
    Srivastava, Navin
    Fulmali, Pradip
    Devhare, Pradip
    Patil, Sanket
    Apurwa, Sachin
    Srinivasan, Ajay
    Datar, Rajan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Dose-ranging and clinical pharmacologic study of arsenic trioxide in patients with advanced hematologic cancers.
    Soignet, SL
    Chanel, S
    Ho, R
    Novick, S
    Warrell, RP
    [J]. BLOOD, 1999, 94 (10) : 279A - 279A
  • [8] Characterizing "no treatment" decisions in patients with advanced-stage cancers.
    Akpoviroro, Ogheneyoma
    Akpoviroro, Oghenetejiro Princess
    Yossef, Kristena
    Castagne, Myriam
    Rodrigues, Elga
    Uwandu, Queeneth
    Bolden, Brian
    Mirza, Wasique
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 76 - 76
  • [9] FOLFIRI in advanced biliary tract cancers.
    Mizrahi, Jonathan
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phani Keerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [10] Phase I/II clinical trial of regorafenib plus durvalumab (MEDI4736) in patients with chemotherapy-refractory advanced biliary tract cancers.
    Al-Rajabi, Raed Moh'd Taiseer
    Kasi, Anup
    Baranda, Joaquina Celebre
    Saeed, Anwaar
    Li, Haoran
    Bruey, Collin
    Best, Shaun
    Phadnis, Milind A.
    Sun, Weijing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS581 - TPS581
12345